As shown in Fig. 6k−m, nebivolol strongly inhibited EGFR expression examined by Pearl Trilogy Imagers and suppressed EGFRL858R/T790M-driven lung tumor formation, as evidenced by a significant reduction of the lung tumor numbers and tumor size. This evidence concerns the gene EGFR and neoplasm.